Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
NPJ Breast Cancer|January 24, 2025
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypesFresia Pareja, Rohit Bhargava, Virginia F Borges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast CancerMargaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2025
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow CategoriesEmad A Rakha, Puay Hoon Tan, Mieke R Van Bockstal, et al.
Archives of Pathology & Laboratory Medicine|January 20, 2024
Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization DefinitionYungtai Lo, Susan C Lester, Ian O Ellis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2025
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further ManagementEmad A Rakha, Cecily Quinn, Wendy Raymond, et al.
Histopathology|April 14, 2025
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteriaPuay Hoon Tan, Ian O Ellis, Kimberly H Allison, et al.
Cell Stem Cell|June 18, 2013
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristicsSibgat Choudhury, Vanessa Almendro, Vanessa F Merino, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 2, 2016
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working groupCarsten Denkert, Stephan Wienert, Audrey Poterie, et al.
NPJ Breast Cancer|May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working GroupMohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.
The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Pageof 27